Literature DB >> 17690586

Continuous evidence of fast HIV disease progression related to class-wide resistance to antiretroviral drugs: a 6 year follow-up analysis of a large observational database.

Zaccarelli Mauro1, Forbici Federica, Lorenzini Patrizia, Ceccherini-Silberstein Francesca, Tozzi Valerio, Trotta Maria Paola, Marconi Patrizia, Narciso Pasquale, Perno Carlo Federico, Antinori Andrea.   

Abstract

Class-wide resistance (CWR) was increasingly associated with a higher risk of HIV progression after 72 months of follow-up among 1392 patients genotypic-tested after failure (AIDS risk 13% for no CWR to 34% for three CWR; AIDS/death risk 21-54%). At multivariate analysis, the detection of two and three CWR was significantly associated with a two and threefold increased risk, respectively, of death and AIDS/death, suggesting that extended resistance is a marker of disease progression in long-term observation.

Entities:  

Mesh:

Year:  2007        PMID: 17690586     DOI: 10.1097/QAD.0b013e328273bbf5

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  3 in total

1.  The role of toxicity-related regimen changes in the development of antiretroviral resistance.

Authors:  Christa R Nevin; Jiatao Ye; Inmaculada Aban; Michael J Mugavero; David Jackson; Hui-Yi Lin; Jeroan Allison; James L Raper; Michael S Saag; James H Willig
Journal:  AIDS Res Hum Retroviruses       Date:  2011-03-21       Impact factor: 2.205

2.  Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.

Authors:  M Zaccarelli; P Lorenzini; V Tozzi; F Forbici; F Ceccherini-Silberstein; C Gori; R D'Arrigo; M P Trotta; P Narciso; C F Perno; A Antinori
Journal:  Infection       Date:  2009-03-09       Impact factor: 3.553

3.  Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options.

Authors:  Kristina L Bajema; Robin M Nance; Joseph A C Delaney; Ellen Eaton; Thibaut Davy-Mendez; Maile Y Karris; Richard D Moore; Joseph J Eron; Benigno Rodriguez; Kenneth H Mayer; Elvin Geng; Cindy Garris; Michael S Saag; Heidi M Crane; Mari M Kitahata
Journal:  AIDS       Date:  2020-11-15       Impact factor: 4.632

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.